NY AG secures $523M from Teva for role in opioid crisis, marking end to opioid litigation

The New York Attorney General's office says it's secured 523 million dollars from Teva Pharmaceuticals and affiliates for its role in the opioid crisis. It effectively marks the end of the state’s litigation against opioid makers and distributors not currently in bankruptcy proceedings.